 defect oral toler promot experiment iga nephropathi oral immun oral toler import featur mucos immun system immune-medi diseas product system igg igm antibodi immunogen present mucos surfac studi role oral toler mucos immunoregul experiment model iga igan import form nephriti human cyclophosphamid estradiol express oral toler chronic oral present Ag balb/c mice drink water bovin gamma globulin bgg wk group mg cyclophosphamid mg estradiol drug group control mice bgg drug separ experi low percentag saline-tr immun mice hematuria nonimmun control mice estradiol and/or cyclophosphamid appropri time signific hematuria drug suboptim time mice hematuria drug-treat immun mice serum igg igm anti-bgg antibodi control salin group immunofluoresc glomerular deposit igg igm drug-treat immun mice saline-tr immun normal untreat control mice hematuria glomerular deposit igg igm serum igg igm antibodi immun mice signific mesangi iga bgg deposit differ deposit saline- drug-treat immun mice blunt oral toler promot system igg igm antibodi product immun mice glomerular immun complex igg and/or igm promot complement deposit hematuria igan analog defect oral mucos toler role genesi symptomat human igan